Trial intelligence / Profile preview

Topical Polyphenon E (Epigallocatechin) for Recessive Nonbullous Congenital Ichthyosis

2009-013656-77Phase 3Active

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Aug 2009
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, double-blind trial of sinecatechins in congenital ichthyosis and lamellar ichthyosis (LI), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Responder rate based on improvement of clinical symptomatology. Started Aug 2009; status: active.

02

Drugs

sinecatechins
03

Conditions

congenital ichthyosislamellar ichthyosis (LI)

Beyond the preview

Go deeper on 2009-013656-77.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013656-77.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call